- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Ulcerative proctitis Ulcerative colitis Crohn disease
- Meeting Date: March 2020
- Public Summary Document (PSD) March 2020 PBAC Meeting - (PDF 831KB)
- Public Summary Document (PSD) March 2020 PBAC Meeting - (Word 167KB)
Mesalazine – March 2020
Mesalazine: Suppository 1g sachet containing granules, 1 g per sachet; Pentasa®
Last updated
3 July 2020